Overview of Dr. Raj
Dr. Nitya Raj is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from University of Michigan Medical School and has been in practice 7 years. She is one of 495 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
University of Michigan Medical SchoolClass of 2010
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2013 - 2026
NJ State Medical License 2020 - 2025
Clinical Trials
- Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Start of enrollment: 2017 Feb 14
- A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide Start of enrollment: 2017 Sep 19
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 260 citationsGenomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.Bastien Nguyen, Christopher Fong, Anisha Luthra, Shaleigh A Smith, Renzo G DiNatale
Cell. 2022-02-03 - 860 citationsMutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha
Nature Medicine. 2017-06-01 - 81 citationsTreatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.Nitya Raj, Emily Valentino, Marinela Capanu, Laura H. Tang, Olca Basturk
Pancreas. 2017-03-01
Press Mentions
- Memorial Sloan Kettering Awards and AppointmentsOctober 16th, 2020
A Study of LEE011 with Everolimus in Patients with Advanced Neuroendocrine TumorsMarch 2nd, 2017
Conquer Cancer Foundation Honors 74 Young Oncologists with Merit AwardsMarch 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
